Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Titel:
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Auteur:
Rescigno, Pasquale Porta, Nuria Finneran, Laura Riisnaes, Ruth Figueiredo, Ines Carreira, Suzanne Flohr, Penny Miranda, Susana Bertan, Claudia Ferreira, Ana Crespo, Mateus Rodrigues, Daniel Nava Gurel, Bora Nobes, Jenny Crabb, Simon Malik, Zafar Ralph, Christy McGovern, Ursula Hoskin, Peter Jones, Robert J. Birtle, Alison Gale, Joanna Sankey, Peter Jain, Suneil McLaren, Duncan Chadwick, Eliot Espinasse, Aude Hall, Emma de Bono, Johann